Analysis of the therapeutic effect of high-voltage, long-term pulse radiofrequency combined with ganglion block in herpes zoster related neuralgia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300071639

Enrollment

Unknown

Registered

2023-05-20

Start date

2023-05-15

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster associated neuralgia

Interventions

High voltage long range pulse radio frequency group :High voltage long range pulse radio frequency

High voltage long-term pulse radiofrequency group combined with ganglion block group:High voltage long-term pulse radiofrequency group combined with ganglion block

Eligibility

Sex/Gender

All

Age

50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Age>50 years old; 2) Have a history of herpes zoster within the past month; 3) Persistent intense pain, even after the skin injury has completely healed, there are still local skin pain allergies, numbness, or sensory abnormalities; 4) Pain has not been treated with standard medications (antiepileptic drugs, antiepileptic drugs, antidepressants, opioid drugs); 5) 24-hour visual analogue scale (VAS) pain score = 5.

Exclusion criteria

Exclusion criteria: 1) Severe coagulation dysfunction or current anticoagulant therapy; 2) Severe liver and kidney dysfunction; 3) Severe cardiopulmonary disease; 4) Intelligence is unable to complete VAS or 36 Short Form Health Survey (SF-36) intervention measures.

Design outcomes

Primary

Measure	Time frame
VAS;	—

Secondary

Measure	Time frame
SF-36;Pregabalin dose;	—

Countries

China

Contacts

Public Contactyinghao song

Jiangsu Subei People's Hospital

425595226@qq.com+86 180 5106 2103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026